In summary, simultaneous delivery of IiOVA, IFNα and IL-12 promoted reprogramming of liver and tumor APCs, including KCs, macrophages and monocytes, boosting their antigen presenting functions and reducing the expression of pro-tumoral genes. This evidence concerns the gene TBCE and neoplasm.